Anti-infective Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Mar 2018| TMR352A| Transparency

Report Highlights

Anti-infective Drugs Market: Overview

This report studies the current as well as future prospects of the global anti-infective drugs market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of anti-infective drugs for pneumothorax and pleural effusion treatment as well as new players planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides overall information and data analysis of the global anti-infective drugs market with respect to the leading market segments based on type, indication, distribution channel, and region.

Based on type, the global anti-infective drugs market has been segmented into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. In terms of indication, the market has been classified into pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, respiratory virus infection, and others. Based on distribution channel, the global anti-infective drugs market has been divided into hospital pharmacy, retail pharmacy, and online sales.

Each of the market segments has been extensively analyzed based on market related factors such as incidence and prevalence of pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection, and respiratory virus infection. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the anti-infective drugs market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global anti-infective drugs market.

Geographically, the global anti-infective drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global anti-infective drugs market.

Key players operating in the global anti-infective drugs market are Merck & Co., Inc., Bayer AG, Pfizer, Inc., Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb, Sanofi, Allergen plc, F. Hoffman-La Roche Ltd., and Johnson and Johnson, among others.

The global anti-infective drugs market has been segmented as follows:

Global Anti-infective Drugs Market, by Type

Anti-bacterial Drugs
B-lactams
Quinolones
Macrolides
Tetracycline
Aminoglycoside
Others (sulfonamide, phenicols)
Anti-fungal Drugs
Azoles
Echinocandins
Polyenes
Others
Anti-viral Drugs

Global Anti-infective Drugs Market, by Indication

Pneumonia
Methicillin-resistant Staphylococcus Aureus (MRSA)
Sepsis
Tuberculosis
Dermatophytosis
Aspergillosis
Candidiasis
Hepatitis Virus Infection
HIV Infection
Respiratory Virus Infection
Others

Global Anti-infective Drugs Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Sales

Global Anti-infective Drugs Market, by Region

North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Asia Pacific
India
Japan
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
  • Table 2 : Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
  • Table 3 : Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
  • Table 4 : Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2025
  • Table 5 : Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
  • Table 6 : Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Region, 2017–2025
  • Table 7 : North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
  • Table 8 : North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
  • Table 9 : North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
  • Table 10 : North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
  • Table 10 : North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
  • Table 12 : North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
  • Table 13 : Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
  • Table 14 : Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
  • Table 15 : Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
  • Table 16 : Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
  • Table 17 : Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
  • Table 18 : Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
  • Table 19 : Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
  • Table 20 : Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
  • Table 21 : Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
  • Table 22 : Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
  • Table 23 : Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
  • Table 24 : Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
  • Table 25 : Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
  • Table 26 : Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
  • Table 27 : Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
  • Table 28 : Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
  • Table 29 : Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
  • Table 30 : Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
  • Table 31 : Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
  • Table 32 : Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
  • Table 33 : Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
  • Table 34 : Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
  • Table 35 : Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
  • Table 36 : Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
  • Figure 1 : Global Anti-infective Drugs Market Snapshot
  • Figure 2 : Global Antiviral Drugs Market Size (US$ Mn) Forecast, 2017–2025
  • Figure 3 : Market Value Share, by Disease Indication (2016)
  • Figure 4 : Market Value Share, by Type (2016)
  • Figure 5 : Market Value Share, by Region (2016)
  • Figure 6 : Market Value Share, by Distribution Channel (2016)
  • Figure 7 : Leading Antibacterial Drugs Sales Analysis, 2014–2016
  • Figure 8 : Leading Antiviral Drugs Sales Analysis, 2014–2016
  • Figure 9 : Global Anti-infective Drugs Market Value Share, by Product, 2016 and 2025
  • Figure 10 : Global Anti-bacterial Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 10 : Global Anti-fungal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 12 : Global Anti-viral Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 13 : Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
  • Figure 14 : Global Anti-infective Drugs Market Value Share, by Disease Indication, 2016 and 2025
  • Figure 15 : Global Pneumonia - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 16 : Global Methicillin-resistant Staphylococcus Aureus (MRSA) - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 17 : Global Sepsis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 18 : Global Tuberculosis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 19 : Global Dermatophytosis- Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 20 : Global Aspergillosis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 21 : Global Candidiasis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 22 : Global Hepatitis Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 23 : Global HIV Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 24 : Global Respiratory Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 25 : Global Others-Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 26 : Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication, 2017–2025
  • Figure 27 : Global Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 28 : Global Hospital Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 29 : Global Retail Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 30 : Global Online Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 31 : Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
  • Figure 32 : Global Anti-infective Drugs Market Value Share, by Region, 2016 and 2025
  • Figure 33 : Anti-infective Drugs Market Attractiveness Analysis, by Region, 2017–2025
  • Figure 34 : North America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
  • Figure 35 : North America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
  • Figure 36 : North America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 37 : North America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
  • Figure 38 : North America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
  • Figure 39 : North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
  • Figure 40 : North America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 41 : North America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 42 : North America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
  • Figure 43 : North America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
  • Figure 44 : North America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
  • Figure 45 : Europe Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
  • Figure 46 : Europe Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
  • Figure 47 : Europe Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 48 : Europe Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
  • Figure 49 : Europe Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
  • Figure 50 : Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
  • Figure 51 : Europe Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 52 : Europe Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 53 : Europe Anti-infective Drugs Market Attractiveness Analysis, by Type, 2016–2025
  • Figure 54 : Europe Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2016–2025
  • Figure 55 : Europe Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2025
  • Figure 56 : Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
  • Figure 57 : Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
  • Figure 58 : Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 59 : Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
  • Figure 60 : Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
  • Figure 61 : Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
  • Figure 62 : Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 63 : Asia Pacific Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 64 : Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
  • Figure 65 : Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
  • Figure 66 : Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
  • Figure 67 : Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
  • Figure 68 : Latin America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
  • Figure 69 : Latin America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 70 : Latin America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
  • Figure 71 : Latin America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
  • Figure 72 : Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
  • Figure 73 : Latin America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 74 : Latin America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2024
  • Figure 75 : Latin America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
  • Figure 76 : Latin America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
  • Figure 77 : Latin America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2024
  • Figure 78 : Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
  • Figure 79 : Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
  • Figure 80 : Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 81 : Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
  • Figure 82 : Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
  • Figure 83 : Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025 Figure highlights market value share of the Anti-infective Drugs Market in Middle East & Africa, by Type –anti-fungal drugs, for 2016 and 2025
  • Figure 84 : Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 85 : Middle East & Africa Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 86 : Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
  • Figure 87 : Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
  • Figure 88 : Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report